ENSURING COMPLIANCE WITH EXTERNAL SUPPLY CHAIN TRANSPARENCY FOR API STRATEGIC SOURCING TEAMS

As direct procurement and strategic sourcing teams explore Active Pharmaceutical Ingredient suppliers for new product development, it is imperative to not only pursue the most cost efficient suppliers but to acquire suppliers who share in a company’s overall compliance objectives. With suppliers contracted by pharmaceutical companies having sub-tier suppliers, challenges arise in ensuring regulatory compliance from the top down as the supplier network becomes a complex web of communication and transparency. For this reason, supply chain monitoring is necessary to expand the depth of knowledge on every entity that plays a role in the development of pharmaceutical therapies to ensure that suppliers are in good standing from a quality perspective and have passed and cooperated with all necessary fees and inspections.

• Internal auditing to ensure supplier transparency and compliance
• Understanding risks associated with external supplier transparency
• Clarifying compliance initiatives with supplier’s external partners

Covington and Burling Speakers:

Jennifer Plitsch
Partner

Grant Young
Associate

Contact:

Brooke Akins | Division Director, Life Science Programs
+1 (312) 224-1693 | bakins@q1productions.com​